|  | Anti-SPP1 | P |
---|---|---|---|
Mean ± SD (OD values) | |||
Mean age ± SD | 63.5 ± 8.2 |  |  |
Age range | 42–88 |  |  |
  <  = 60 | 55 | 0.3320 ± 0.1079 | 0.051 |
  > 60 | 107 | 0.3712 ± 0.1412 | |
Sex | |||
 Male | 109 | 0.3491 ± 0.1242 | 0.223 |
 Female | 53 | 0.3760 ± 0.1461 | |
Smoking | |||
 Yes | 54 | 0.3402 ± 0.1362 | 0.165 |
 None | 99 | 0.3718 ± 0.1330 | |
Drinking | |||
 Yes | 45 | 0.3587 ± 0.1454 | 0.903 |
 None | 106 | 0.3616 ± 0.1310 | |
Differentiation | |||
 Moderate and high | 40 | 0.3728 ± 0.1520 | 0.344 |
 Low | 30 | 0.3407 ± 0.1207 | |
TNM stage | |||
 I-II | 49 | 0.3378 ± 0.1330 | 0.286 |
 III—IV | 48 | 0.3665 ± 0.1303 | |
Lymphatic metastasis | |||
 Positive | 53 | 0.3404 ± 0.1142 | 0.600 |
 Negative | 52 | 0.3537 ± 0.1430 | |
Distance metastasis | |||
 Positive | 14 | 0.3814 ± 0.1309 | 0.346 |
 Negative | 85 | 0.3458 ± 0.1305 | |
Family tumor history | |||
 Yes | 13 | 0.4623 ± 0.1587 | 0.004 |
 None | 138 | 0.3497 ± 0.1283 |